830842P

08:0 PA

1,2-dioctanoyl-sn-glycero-3-phosphate (sodium salt), powder

• 別名: PA(8:0/8:0)
• 実験式（ヒル表記法）: C₁₉H₃₆O₈PNa
• CAS番号: 321883-54-9
• 分子量: 446.45
• UNSPSCコード: 51191904
• NACRES: NA.25

特性

• アッセイ: >99% (TLC)
• 形状: powder
• 包装: pkg of 1 × 10 mg (830842P-10mg); pkg of 1 × 25 mg (830842P-25mg)
• メーカー／製品名: Avanti Research^™ - A Croda Brand 830842P
• 脂質タイプ: cardiolipins; phospholipids
• 輸送温度: dry ice
• 保管温度: −20°C
• SMILES記法: [H][C@@](COP([O-])(O)=O)(OC(CCCCCCC)=O)COC(CCCCCCC)=O.[Na+]
• InChI: 1S/C19H37O8P.Na/c1-3-5-7-9-11-13-18(20)25-15-17(16-26-28(22,23)24)27-19(21)14-12-10-8-6-4-2;/h17H,3-16H2,1-2H3,(H2,22,23,24);/q;+1/p-1/t17-;/m1./s1
• InChI Key: ZNDNSOYDPUTHKQ-UNTBIKODSA-M

詳細

詳細

Phosphatidic acid is obtained from glycerophospholipid with the help of phospholipase D. 08:0 PA/1,2-dioctanoyl-sn-glycero-3-phosphate (C8-PA) is an mammalian target of rapamycin (mTOR) activator.

アプリケーション

08:0 PA may be used to activate p-mTOR in order to assess whether the observed apoptotic effect of histone deacetylase inhibitors (HDACIs) is related to mammalian target of rapamycin (mTOR) pathway signaling.

生物化学的／生理学的作用

Phosphatidic acid might serve as a modulator of phagocyte respiratory burst. It also acts as a precursor of diacylglycerol and lysophosphatidic acid. 08:0 PA/C8-PA has the ability to affect the phosphorylation of mammalian target of rapamycin (mTOR) and the viability of gallbladder carcinoma cells, that are treated with histone deacetylase inhibitors (HDACIs).

包装

5 mL Clear Glass Sealed Ampule (830842P-10mg)

5 mL Clear Glass Sealed Ampule (830842P-25mg)

法的情報

Avanti Research is a trademark of Avanti Polar Lipids, LLC

安全性情報

• 保管分類コード: 11 - Combustible Solids